Shannon Morris - Apr 10, 2023 Form 3 Insider Report for Erasca, Inc. (ERAS)

Role
Chief Medical Officer
Signature
/s/ Shannon Morris
Stock symbol
ERAS
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
3
Date filed
4/13/2023, 08:21 PM
Next filing
Feb 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ERAS Stock Option (Right to Buy) Apr 10, 2023 Common Stock 300K $7.91 Direct F1
holding ERAS Stock Option (Right to Buy) Apr 10, 2023 Common Stock 161K $4.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on May 2, 2023, the one-year anniversary of the vesting commencement date, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F2 1/48th of the shares subject to the option vest monthly following February 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.